This month, the FDA released a report titled “Review of Published Literature between 2008 and 2018 of Relevance to Radiofrequency Radiation and Cancer.” The findings said there’s “no consistent pattern” to link radiofrequency radiation, or RFR, to tumors or cancer.”
MIT Technology Review reported that the study reviewed 125 experiments carried out on animals and 75 on humans between 2008 and August 2019. MIT also noted overarching problems regarding both the animal and human studies.
Notably, rats don’t mimic how humans actually use their cell phones. According to MIT, animal studies often douse a rat’s entire body in radiation at levels that are far higher than what humans are typically exposed to when using cell phones. The human studies were also flawed, relying only on questionnaires from family members or observational data.
Regarding heightened concerns over radiation and 5G, the FDA says infrastructure falls within current exposure guidelines. The guidelines state humans can safely be exposed to radiation between 300 kHz and 100 GHz, and 5G currently spans the range between 25.250 GHz and less than 100 GHz.
The FCC has repeatedly insisted that 5G is safe, and the FDA report agrees: “Existing epidemiological evidence indicates that if any risk does exist, it is extremely low compared to both the natural incidence of the disease and known controllable risk factors.” Even with these findings, the FDA urged researchers to continue studying the effects of cell phones on humans, particularly those predisposed to tumors, reported MIT.
Reader Interactions